Create Alert
Watchlist

Alkem Laboratories

₹5,670.50
+45.50 (0.81%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
5,615.00
Prev. Close
5,625.00
Volume
44,999
Total traded value
25.52 Cr
Upper Circuit
6,187.50
Lower Circuit
5,062.50

Fundamentals

Market Cap₹67,295Cr
ROE17.69%
P/E Ratio(TTM)27.92
EPS(TTM)201.58
P/B Ratio5.04
Dividend Yield0.80%
Industry P/E33.01
Book Value1116.21
Debt to Equity0.18
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Alkem Laboratories

For over five decades, Alkem Laboratories has been a leading force in India's pharmaceutical landscape, dedicated to ensuring quality, accessibility, and trust in healthcare. The company's core mission is to extend lifecare beyond all boundaries, viewing each treatment as a means to safeguard futures and nurture families. It operates with a dual commitment to strengthening its present operations while also building for the future, which guides every strategic decision made. The company operates across the pharmaceutical value chain, focusing on branded generics, complex generics, biosimilars, and nutraceuticals to meet global healthcare needs. While maintaining its leadership in acute therapies, the company is also experiencing promising growth in chronic segments like anti-diabetics and neurology. Alkem proudly ranks among the top five pharmaceutical companies in India, with its leading brands like Clavam and Pan-D featuring among the nation's top 50.;
Parent OrganisationAlkem Laboratories
Managing DirectorDr. Vikas Gupta
NSE SymbolALKEM

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
51.20%
Retail And Others
17.40%
Mutual Funds
16.94%
Foreign Institutions
9.48%
Other Domestic Institutions
4.99%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
40.76
Cipla
NA
(0.00%)
22.36
Dr Reddy's Laboratories
NA
(0.00%)
17.82
Zydus Lifesciences
NA
(0.00%)
18.54